| 000 | 01739 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515015630.0 | ||
| 264 | 0 | _c20060504 | |
| 008 | 200605s 0 0 eng d | ||
| 022 | _a1535-7163 | ||
| 024 | 7 |
_a10.1158/1535-7163.MCT-05-0340 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTakebe, Naoko | |
| 245 | 0 | 0 |
_aIMP dehydrogenase inhibitor mycophenolate mofetil induces caspase-dependent apoptosis and cell cycle inhibition in multiple myeloma cells. _h[electronic resource] |
| 260 |
_bMolecular cancer therapeutics _cFeb 2006 |
||
| 300 |
_a457-66 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCaspases _xmetabolism |
| 650 | 0 | 4 |
_aCell Cycle _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCyclin-Dependent Kinase Inhibitor p21 _xmetabolism |
| 650 | 0 | 4 |
_aGuanosine _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIMP Dehydrogenase _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aMultiple Myeloma _xenzymology |
| 650 | 0 | 4 |
_aMycophenolic Acid _xanalogs & derivatives |
| 650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xmetabolism |
| 650 | 0 | 4 |
_aSTAT3 Transcription Factor _xmetabolism |
| 700 | 1 | _aCheng, Xiangfei | |
| 700 | 1 | _aFandy, Tamer E | |
| 700 | 1 | _aSrivastava, Rakesh K | |
| 700 | 1 | _aWu, Suhlan | |
| 700 | 1 | _aShankar, Sharmila | |
| 700 | 1 | _aBauer, Kenneth | |
| 700 | 1 | _aShaughnessy, John | |
| 700 | 1 | _aTricot, Guido | |
| 773 | 0 |
_tMolecular cancer therapeutics _gvol. 5 _gno. 2 _gp. 457-66 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/1535-7163.MCT-05-0340 _zAvailable from publisher's website |
| 999 |
_c16115721 _d16115721 |
||